News

Protalix BioTherapeutics Sets Its Sights on 2025 BIO CEO Conference

Protalix BioTherapeutics Sets Its Sights on 2025 BIO CEO Conference

Protalix BioTherapeutics Prepares for the 2025 BIO CEO Conference

Protalix BioTherapeutics, Inc. (NYSE American:PLX), a pioneer in biopharmaceutical innovation, is set to make a significant impression at the upcoming BIO CEO & Investor Conference. Scheduled for February 11, 2025, at 10:15 AM EST, Protalix will present its remarkable developments at this highly anticipated gathering in New York.

Understanding Protalix's Role in Biopharmaceuticals

Protalix is celebrated for its focus on developing and commercializing recombinant therapeutic proteins through its cutting-edge ProCellEx plant cell-based expression system. This innovative method enables the production of proteins at an industrial scale, representing a paradigm shift in biopharmaceutical manufacturing.

A Unique Claim to FDA Approval

As the first company to receive U.S. Food and Drug Administration (FDA) approval for a protein produced via a plant cell-based suspension expression system, Protalix has established itself as a leader in this niche. Among its impressive lineup of products is taliglucerase alfa, which treats Gaucher disease and has been licensed to Pfizer Inc. for global development, excluding Brazil, where Protalix retains full commercialization rights.

Advancements in Therapeutic Products

The company’s second innovation, Elfabrio, gained FDA and European Medicines Agency approval in May 2023, further exemplifying Protalix’s dedication to addressing pressing medical needs. The collaboration with Chiesi Farmaceutici S.p.A. for Elfabrio’s global development illustrates Protalix's commitment to expanding its reach in the biopharmaceutical market.

Upcoming Presentation at the BIO CEO & Investor Conference

At the BIO CEO & Investor Conference, Protalix management will provide valuable insights into its strategic goals and upcoming projects. The presentation is not only an opportunity to highlight successes but also a platform for engaging with potential investors and partners willing to explore the company's innovative pipeline.

Encouraging Investor Engagement

Following the presentation, interested participants are encouraged to engage with Protalix's management through one-on-one meetings, thus fostering relationships and discussing possible collaborations. Protalix aims to ensure that its stakeholders are well-informed about its future endeavors and technological advancements.

Innovative Pipeline of Therapeutic Candidates

Protalix boasts a robust pipeline featuring proprietary versions of recombinant therapeutic proteins targeting various established pharmaceutical markets. Notable candidates include PRX–115, designed for treating uncontrolled gout, and PRX–119, aiming to tackle diseases related to NETs. This pipeline showcases the company’s continuous commitment to addressing critical health issues through innovative biopharmaceutical solutions.

Protalix's Commitment to Excellence

The dedication of Protalix BioTherapeutics to excellence in biopharmaceutical development is evident through its strategic collaborations and innovative product offerings. With a forward-looking approach and a passion for advancing healthcare, Protalix remains a key player in the biopharmaceutical landscape.

Frequently Asked Questions

What is Protalix BioTherapeutics known for?

Protalix BioTherapeutics is known for its development and commercialization of recombinant therapeutic proteins using its ProCellEx plant cell-based expression system.

When will Protalix present at the BIO CEO & Investor Conference?

Protalix is scheduled to present on February 11, 2025, at 10:15 AM EST.

What product has Protalix developed for Gaucher disease?

Protalix developed taliglucerase alfa for the treatment of Gaucher disease, which has been licensed for global development to Pfizer Inc.

Which recent product approvals has Protalix achieved?

Protalix’s second product, Elfabrio, received approval from both the FDA and the European Medicines Agency in May 2023.

What are some of Protalix's therapeutic candidates in development?

Protalix is developing several candidates, including PRX–115 for uncontrolled gout treatment and PRX–119 for NETs-related diseases.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Composites One Unveils Game-Changing eCommerce Platform

Updated Category News Views 21

A New Era for Composites One? You know how companies often blast updates nobody asked for? Well, Composites One finally flipped the script. They've rolled out a completely revamped eCommerce platform across North America, and here's the kicker—it's actually built from the ground up on customer feedback. Yeah, they took the time to ask manufacturers what they needed for...

Continue Reading
Andrea P. Davis: A Leadership Luminary Honored

Updated Category News Views 138

A Decade-Spanning Influence in Leadership After years of helping executives navigate the twists and turns of organizational life, Andrea P. Davis stands out as The Inner Circle's Pinnacle Professional of the Year. With over 25 years under her belt, Davis has tackled strategic planning, brand development, and organizational transformation like a prizefighter in the ring....

Continue Reading
New Study Exposes Grim Reality for Moderate Aortic Stenosis

Updated Category News Views 86

Uncovering the Stark Truth of Moderate Aortic Stenosis When you hear about heart issues, the last thing you want to think about is moderate anything. But this study out of San Diego sure throws a wrench in how we size up moderate aortic stenosis. Turns out these patients aren't just in a holding pattern—they're facing some serious storm clouds. High Stakes for...

Continue Reading
Magnolia's Data Breach Raises Eyebrows and Concerns

Updated Category News Views 84

Data Security Breach: Today's Digital Nightmare In the relentless digital jungle we live in, someone’s email account is like a treasure trove for cybercriminals sniffing around for their next haul. And that’s precisely what went down at Magnolia Management Company, LLC out in East Longmeadow, Massachusetts. It was April 3, 2026, when they stumbled upon some...

Continue Reading
Potomac Edison Targets Virginia Grid Revamp by 2030

Updated Category News Views 135

Strengthening the Backbone of Virginia's Power Supply Ever had your lights flicker on a windy day and wondered if the power grid would hold? Potomac Edison, under the banner of FirstEnergy Corp., is stepping up with a game plan to fortify the electric spine of Virginia and its neighbors. They're diving into a multi-state adventure, rebuilding and erecting 138 kV...

Continue Reading
MSA Safety's Q3 2026: Strong Sales, Strategic Moves

Updated Category News Views 31

MSA's Stellar Growth Amidst Strategic Shifts Ah, the rush of quarterly results, and today we're eyeballing MSA Safety's third quarter of 2026. If numbers light your fire, MSA's boasting some scorching ones right now. The company's net sales shot up to $536 million—a 15% leap from the previous year. Now, in this dog's game of margins and market maneuvers, that's a solid...

Continue Reading
Nordic Chips Slash Power Use, Boost Edge AI on Wi-Fi

Updated Category News Views 72

Nordic Semiconductor's Cutting-Edge Leap Let's cut through the noise: Nordic Semiconductor's latest move in the wireless landscape is a big deal, especially if you're the sort counting beans down to the last cent. Their fresh-off-the-press nRF71 Series of Systems-On-Chip (SoCs) pulls off a neat trick: it delivers Wi-Fi, Bluetooth LE, Thread, and edge AI on one chip, and...

Continue Reading
CNTE's BloombergNEF Tier 1 Nod: A New Era Begins

Updated Category News Views 63

Diving Deep into CNTE's Latest Achievement The energy storage game has a new major player, and it's none other than Contemporary Nebula Technology Energy Co., Ltd. (CNTE). November 3, 2026, wasn't just another autumn day in London—it was a stage for CNTE to mark its entry onto BloombergNEF's Q4 2026 Tier 1 Energy Storage Manufacturers List. This ain't just another...

Continue Reading
TAL's Festive Drinkware Hits Walmart for the Holidays

Updated Category News Views 65

Walmart's Shelves Get Festive with TAL's New Lineup Alright, so we've got TAL rolling out a limited-edition Holiday Coffee Collection exclusively at Walmart stores. You might wonder why a hydration brand is grabbing headlines right now, but listen up—this stuff just hit on November 2 and it's got the sparkle everyone's eyeing this season. What's Inside this Festive...

Continue Reading
Planning Your Pergola: DIY Backyard Transformation

Updated Category News Views 34

Blueprint for a Backyard Upgrade Transforming a backyard isn't just about nailing down the aesthetics with a motorized pergola. The real magic is in thoughtful planning—right from the get-go. Whether you've got your sights set on the sleek FlexPatio motorized pergola kits or another setup, it all begins with a mental blueprint before a single speck of dirt is disturbed....

Continue Reading

Top 5 Most Recently Viewed Articles

How Elon Musk's PAC is Influencing Pro-Trump Campaigns

Updated Category News Views 110

Elon Musk's PAC Investment in Pro-Trump Campaigns Building America's Future, a political action committee (PAC) backed by Elon Musk, has made significant investments exceeding a million dollars aimed at promoting recent White House successes. These include a Republican policy package that Musk previously criticized. The Launch of the Pro-Trump Ad Campaign The PAC is...

Continue Reading
Insights into the Latest Trends in CTV Advertising for 2024

Updated Category News Views 495

Insights into Connected TV Advertising Trends London, March 26, 2025—Pixalate has unveiled a significant report spotlighting the latest movements within the Connected TV (CTV) advertising landscape for the fourth quarter of 2024. This report offers a comprehensive analysis of trends observed globally, particularly focusing on key markets in Canada. Key Highlights of the...

Continue Reading
Exploring the Growth of the Passenger Information System Market

Updated Category News Views 112

Passenger Information System Market Overview The global passenger information system market is experiencing unprecedented growth and is set to reach an impressive value of USD 74.64 billion by 2031. This remarkable increase is expected to occur alongside a compound annual growth rate (CAGR) of 12.4% during the forecast period from 2024 to 2031. The surge in demand for...

Continue Reading
Christine Tammara Steps Up as PepsiCo's New Controller

Updated Category News Views 407

Introducing Christine Tammara as Senior Vice President and Controller PepsiCo, Inc. (NASDAQ: PEP) is making headlines with the appointment of Christine Tammara as their new Senior Vice President and Controller. This significant transition comes as Tammara is set to succeed Marie Gallagher, who has announced her retirement plans. The effective date for this transition is...

Continue Reading
Reimagining Financial Systems: Buterin on Prediction Markets

Updated Category News Views 155

Buterin Explores the World of Prediction Markets Vitalik Buterin, the visionary behind Ethereum (CRYPTO: ETH), recently shared his thoughts about prediction markets, describing them as a healthier alternative to traditional financial environments. His insights come from a deep understanding of market dynamics and a passion for fostering accountability in economic systems....

Continue Reading